{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:19:59Z","timestamp":1774430399008,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013554","name":"Foundation for Women and Girls with Blood Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.rpth.2024.102422","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T03:30:34Z","timestamp":1714102234000},"page":"102422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of an automated von Willebrand factor glycoprotein IbM activity assay compared with 3 alternative von Willebrand factor activity assays"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-407X","authenticated-orcid":false,"given":"Kenneth D.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1767-2882","authenticated-orcid":false,"given":"Martina","family":"B\u00f6hm-Weigert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis J.","family":"Dietzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Eby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Flickinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4117-7588","authenticated-orcid":false,"given":"Walter","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandice","family":"Kottke-Marchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-4585","authenticated-orcid":false,"given":"Thomas L.","family":"Ortel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Patzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2558-2089","authenticated-orcid":false,"given":"Steven W.","family":"Pipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Anil","family":"Timur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-5158","authenticated-orcid":false,"given":"Ravindra","family":"Sarode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102422_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102422_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10408363.2021.2014781","article-title":"Von Willebrand factor and disease: a review for laboratory professionals","volume":"59","author":"Harris","year":"2022","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.rpth.2024.102422_bib3","article-title":"Laboratory diagnosis of von Willebrand disease in the age of the new guidelines: considerations based on geography and resources","volume":"30","author":"Favaloro","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102422_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fcvm.2019.00141","article-title":"Shear-dependent platelet aggregation: mechanisms and therapeutic opportunities","volume":"6","author":"Rana","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rpth.2024.102422_bib5","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-019-11474-5","article-title":"Crystal structure and substrate-induced activation of ADAMTS13","volume":"10","author":"Petri","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.rpth.2024.102422_bib6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102422_bib7","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102422_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0033-1353442","article-title":"Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defect","volume":"39","author":"Othman","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102422_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0033-1334867","article-title":"Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update","volume":"39","author":"Federici","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102422_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102422_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bod\u00f3","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102422_bib12","first-page":"318","article-title":"Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor","volume":"85","author":"Allain","year":"1975","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.rpth.2024.102422_bib13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/ajh.25393","article-title":"Automated assays for von Willebrand factor activity","volume":"94","author":"Higgins","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2024.102422_bib14","first-page":"75","article-title":"Laboratory testing for von Willebrand disease: the past, present, and future state of play for von Willebrand factor assays that measure platelet binding activity, with or without ristocetin","volume":"43","author":"Just","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102422_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102422_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2141.1985.tb07350.x","article-title":"An immunoradiometric assay for human factor VIII\/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope","volume":"59","author":"Goodall","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102422_bib17","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1055\/s-0038-1657727","article-title":"von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use","volume":"78","author":"Murdock","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102422_bib18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3324\/haematol.10766","article-title":"Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease","volume":"92","author":"Pinol","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102422_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1309\/CEPND3LFHQ87XU4D","article-title":"A\u00a0new automated screening assay for the diagnosis of von Willebrand disease","volume":"127","author":"Salem","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rpth.2024.102422_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/hae.12203","article-title":"Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method","volume":"19","author":"Cabrera","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102422_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12380","article-title":"Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies","volume":"20","author":"Costa-Pinto","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102422_bib22","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","article-title":"Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin","volume":"25","author":"Patzke","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2024.102422_bib23","series-title":"Measurement procedure comparison and bias estimation using patient samples; approved guideline","year":"2018"},{"key":"10.1016\/j.rpth.2024.102422_bib24","series-title":"Defining, establishing, and verifying reference interval in the clinical laboratory; approved guideline","year":"2010"},{"key":"10.1016\/j.rpth.2024.102422_bib25","series-title":"Evaluation of precision of quantitative measurement procedures; approved guideline","year":"2014"},{"key":"10.1016\/j.rpth.2024.102422_bib26","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/jth.14206","article-title":"An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study","volume":"16","author":"Szederjesi","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102422_bib27","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jth.14145","article-title":"A\u00a0comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients","volume":"6","author":"Vangenechten","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102422_bib28","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/jth.14319","article-title":"Clinically relevant differences between assays for von Willebrand factor activity","volume":"16","author":"Boender","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102422_bib29","article-title":"A\u00a0comparative study in patients with type 2 von Willebrand disease using 4 different platelet-dependent von Willebrand factor assays","volume":"7","author":"Colpani","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102422_bib30","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102422_bib31","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/j.1538-7836.2012.04905.x","article-title":"Age dependency of coagulation parameters during childhood and puberty","volume":"10","author":"Appel","year":"2012","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924001110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924001110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T05:32:36Z","timestamp":1722144756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924001110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2475037924001110"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102422","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of an automated von Willebrand factor glycoprotein IbM activity assay compared with 3 alternative von Willebrand factor activity assays","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102422"}}